Showing results (861-870 of 5,480) with videos related to
Sort By:
Pageof 548
Pharmacotherapy|January 1, 1988
A comparative trial of digoxin and digitoxin in the treatment of congestive heart failureH I Bussey, D W Hawkins, J J Gaspard, et al.Pharmacotherapy|January 24, 2020
Establishing the Therapeutic Index of Fluid Resuscitation in the Septic Patient: A Narrative Review and Meta-AnalysisPaul M Reynolds, Lauren Wells, Robert MacLaren, et al.Pharmacotherapy|September 28, 2005
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxoneJohn F Mohr, Peggy S McKinnon, Patti J Peymann, et al.Pharmacotherapy|September 28, 2005
Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patientsRobert MacLaren, Patrick W SullivanPharmacotherapy|September 28, 2005
Effect of Ginkgo biloba extract on plasma steroid concentrations in healthy volunteers: a pilot studyJohn S Markowitz, C Lindsay DeVane, John G Lewis, et al.Pharmacotherapy|March 24, 2006
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunctionTyree H Kiser, Douglas N FishPharmacotherapy|March 24, 2006
Factors associated with drug adherence and blood pressure control in patients with hypertensionAndrew B Morris, Jingjin Li, Kurt Kroenke, et al.Pharmacotherapy|March 24, 2006
Use of drotrecogin alfa (activated) in older patients with severe sepsisSherri L Alexander, Frank R ErnstPharmacotherapy|March 24, 2006
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumoniaMarc H Scheetz, Richard G Wunderink, Michael J Postelnick, et al.Pharmacotherapy|April 28, 2006
The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of careDan Lender, Suzanne K SyskoPageof 548